FDA Clearance Tracker · P100045-S050
Cardiomems HF System
Last checked: Nov 20, 2026Latest source record: Apr 6, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Apr 6, 2021
Approved
Time to decision
28 days
Received Mar 9, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P100045-S050
- Device name
- Cardiomems HF System
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Atlanta, GA
- Received
- Mar 9, 2021
- Decided
- Apr 6, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P100045
Device type
- Device type
- System, hemodynamic, implantable (MOM)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for manufacturing sites located at Midwest Sterilization Corporation, PO BOX 411, 1204 Lenco Avenue, Jackson, Missouri, USA, FEI: 1928237 for Ethylene Oxide Sterilization and Sterigenics US, LLC, 5725 W. Harold Gatty Drive, Salt Lake City, Utah, USA, FEI: 1721676 for Ethylene Oxide Sterilization.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.